Effect of antiretroviral therapy initiation time and baseline CD4+ cell counts on AIDS-related mortality among former plasma donors in China: a 21-year retrospective …

Y Yang, Y Li, X Zhang, W Zhang, Y Ma, X Jia… - Global Health …, 2021 - Taylor & Francis
Background The conventional survival analysis model on HIV/AIDS prognosis is the Cox
proportional hazard model, which deals with only one event type, death, regardless of the …

The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China

F Zhang, Z Dou, L Yu, J Xu, JH Jiao… - Clinical infectious …, 2008 - academic.oup.com
Abstract Background. In China, many former plasma donors were infected with the human
immunodeficiency virus (HIV) in the early–mid-1990s. Highly active antiretroviral therapy …

Survival analysis on Former Plasma Donors living with HIV/AIDS after initiation of antiretroviral therapy in Henan province, 2002-2017

Y Liang, WJ Yang, DY Sun, N Li… - … liu xing bing xue za zhi …, 2019 - europepmc.org
Objective: To explore the survival status and influencing factors on former plasma donors
(FPD) living with HIV/AIDS after initiation of antiretroviral therapy (ART) during 2002-2017 in …

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV …

S Kiertiburanakul, D Boettiger, MP Lee… - Journal of the …, 2014 - Wiley Online Library
Introduction Although antiretroviral therapy (ART) has been rapidly scaled up in Asia, most
HIV‐positive patients in the region still present with late‐stage HIV disease. We aimed to …

Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study

Y Zhao, Z Wu, JM McGoogan, CX Shi… - Clinical Infectious …, 2018 - academic.oup.com
Background Clinical trials have demonstrated that immediate initiation of antiretroviral
therapy (ART) reduces AIDS-related morbidity and mortality. We tested the hypothesis that …

Survival time and associated factors of 8 310 AIDS patients initially receiving antiretroviral treatment of Liangshan Yi Autonomous Prefecture, Sichuan province of …

G Zhang, Y Gong, Q Wang, S Zhang, Q Liao… - … yu Fang yi xue za zhi …, 2015 - europepmc.org
Objective To investigate the survival time and its impact factors among AIDS patients who
initially received antiretroviral treatment (ART) of Liangshan Yi Autonomous Prefecture …

A comparative analysis on characteristics and mortalities of four key transmission populations on antiretroviral therapy: a retrospective cohort study in Northwest China

S Feng, Z Zhu, P Yang, J Jin, H Tuo, N Wang… - BMC Infectious …, 2022 - Springer
Background This study explored disparities in characteristics and mortalities among four
major transmission groups on antiretroviral therapy in northwest China as well as the …

Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study

Y Huang, O Zhou, Z Zheng, Y Xu, Y Shao, C Qin… - AIDS Research and …, 2020 - Springer
Objective To evaluate the impact of AIDS-defining events (ADE) on long-term mortality of
HIV positive individuals on antiretroviral therapy (ART), a retrospective HIV/AIDS treatment …

Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study

Z Tang, SW Pan, Y Ruan, X Liu, J Su, Q Zhu, Z Shen… - Scientific reports, 2017 - nature.com
Current WHO guidelines recommend initiating ART regardless of CD4+ cell count. In
response, we conducted an observational cohort study to assess the effects of pre-ART …

A retrospective cohort study on survival time of AIDS death cases receiving Antiretroviral Therapy and related factors

L Hao, X Zhu, G Wang, B Lin, Y Qian, X Tao… - … yu fang yi xue za zhi …, 2014 - europepmc.org
Methods A retrospective cohort study was carried out to collect the data on death cases
receiving Antiretroviral Therapy by the National HIV/AIDS Comprehensive Response …